4//SEC Filing
BELTRAMELLO JO ANN 4
Accession 0001179110-20-008883
CIK 0001235010other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:40 PM ET
Size
15.5 KB
Accession
0001179110-20-008883
Insider Transaction Report
Form 4
BELTRAMELLO JO ANN
Chief HR and Inf. Officer
Transactions
- Exercise/Conversion
CommonStock
2020-08-07$18.85/sh+2,690$50,707→ 59,796 total - Sale
Common Stock
2020-08-07$32.00/sh−2,690$86,080→ 58,452 total - Exercise/Conversion
Common Stock
2020-08-07+1,346→ 61,142 total - Sale
Common Stock
2020-08-10$32.36/sh−622$20,128→ 57,830 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-07−1,326→ 10,888 totalExercise: $18.85From: 2019-05-07Exp: 2027-02-07→ Common Stock (1,326 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-07−1,364→ 21,400 totalExercise: $18.85From: 2018-02-07Exp: 2027-02-07→ Common Stock (1,364 underlying) - Exercise/Conversion
Restricted Stock Units
2020-08-07−1,346→ 2,691 total→ Common Stock (1,346 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F3]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F4]Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001755174
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:40 PM ET
- Size
- 15.5 KB